Page last updated: 2024-09-05

cilengitide and Carcinoma, Lewis Lung

cilengitide has been researched along with Carcinoma, Lewis Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, E; Harris, AL1
Alrawashdeh, W; Cereser, B; Crnogorac-Jurcevic, T; Demircioglu, F; Elia, G; Ghazaly, E; Hagemann, T; Hodivala-Dilke, KM; Kocher, HM; McDonald, S; Scudamore, CL; Stratford, MR; Wong, PP1

Other Studies

2 other study(ies) available for cilengitide and Carcinoma, Lewis Lung

ArticleYear
Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy.
    Cancer cell, 2015, Jan-12, Volume: 27, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Lewis Lung; Deoxycytidine; Gemcitabine; Humans; Pancreatic Neoplasms; Snake Venoms; Verapamil

2015
Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
    Cancer cell, 2015, Jan-12, Volume: 27, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Snake Venoms; Verapamil

2015